查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585765

骨髓移植市场：按类型、治疗类型、最终用户划分 - 2025-2030 年全球预测

Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年骨髓移植市值为162.7亿美元，预计到2024年将达到176.2亿美元，复合年增长率为8.74%，预计到2030年将达到292.6亿美元。

骨髓移植 (BMT) 涉及以健康的骨髓干细胞取代受损或患病的骨髓，这对于治疗白血病、淋巴瘤和其他血液疾病等疾病至关重要。自体、同种异体和同基因移植可供选择，每种移植都满足不同的临床需求，将其应用扩展到各种血液学和免疫不全症。这些疾病的日益普及正在推动 BMT 的需求和应用，并得到医疗技术进步和政府支持政策的进一步支持。 BMT 意识的提高、成功率的提高以及干细胞捐赠者数量的增加是成长的主要驱动力。然而，它面临着高昂的手术成本、严格的监管以及移植物抗宿主疾病等併发症风险等挑战，这可能会限制市场的成长轨迹。

主要市场统计
基准年[2023] 162.7亿美元
预测年份 [2024] 176.2亿美元
预测年份 [2030] 292.6亿美元
复合年增长率（%） 8.74%

最终用途范围主要是医院、诊所和专门的癌症治疗中心，并不断增加对先进 BMT 设施的投资，以提高治疗效果和患者预后。最近的市场开拓趋势揭示了基因匹配技术和干细胞冷冻保存的潜在商机。该领域的公司可以透过专注于个人化医疗和改善捐赠者-接受者配对系统的物流来利用这些趋势。此外，减少移植后併发症的技术创新为产业相关人员提供了宝贵的研发途径。迫切需要具有成本效益的治疗通讯协定和以患者为中心的护理模式来缓解限制。

市场的本质是动态的，对再生医学和基因组学研究有强烈的倾向，为创新提供了肥沃的土壤。专注于将人工智慧融入治疗计划并利用远端医疗进行咨询的公司可以提高可及性和业务效率。透过优先与学术研究机构合作以促进创新，相关人员可以确保竞争优势。因此，瞄准免疫疗法的进步、加强全球捐助者登记以及投资于公众意识宣传活动是抓住新市场机会并促进 BMT 市场持续增长的战略倡议。

市场动态：揭示快速发展的骨髓移植市场的关键市场洞察

供需的动态交互作用正在改变骨髓移植市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 血癌的盛行率和改善骨髓移植的机会
    • 细胞治疗和组织工程产品的商业化程度提高
    • 政府努力提高治疗方法意识
  • 市场限制因素
    • 治疗费用上涨且无法报销
  • 市场机会
    • 骨髓移植治疗的技术进步
    • BMT 正在进行的研发活动
  • 市场挑战
    • 对 GVHD、感染疾病和復发的担忧

波特五力：驾驭骨髓移植市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解骨髓移植市场的外部影响

外部宏观环境因素在塑造骨髓移植市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解骨髓移植市场的竞争格局

骨髓移植市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵骨髓移植市场供应商的绩效评估

FPNV定位矩阵是评估骨髓移植市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製骨髓移植市场的成功之路

骨髓移植市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高血癌骨髓移植的盛行率和可近性
      • 细胞治疗和组织工程产品的商业化程度提高
      • 政府努力提高治疗方法意识
    • 抑制因素
      • 治疗费用高且无补偿
    • 机会
      • 骨髓移植治疗的技术进步
      • BMT 正在进行的研发活动
    • 任务
      • 对 GVHD、感染疾病和復发的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章骨髓移植市场：依类型

  • 同种异体移植
  • 自体移植

第七章依治疗类型分類的骨髓移植市场

  • 再生障碍性贫血
  • 白血病
  • 淋巴瘤
  • 骨髓发育不良症候群
  • 骨髓瘤
  • 骨髓增生性疾病
  • 镰状细胞性贫血
  • 固态肿瘤
  • 地中海型贫血

第八章骨髓移植市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 多学科诊所

第九章 北美及南美骨髓移植市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太骨髓移植市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲骨髓移植市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • American Type Culture Collection
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • FUJIFILM Cellular Dynamics, Inc.
  • Gamida Cell
  • Hemacare Corporation
  • Lifeline Cell Technology
  • Lonza Group AG
  • Magenta Therapeutics, Inc.
  • Merck KgaA
  • Mesoblast Ltd.
  • Novartis AG
  • PromoCell GmbH
  • Qiagen NV
  • ReeLabs Pvt. Ltd.
  • Sanofi-Aventis LLC
  • ScienCell Research Laboratories, Inc.
  • STEMCELL Technologies Inc.
Product Code: MRR-957C47F8F271

The Bone Marrow Transplantation Market was valued at USD 16.27 billion in 2023, expected to reach USD 17.62 billion in 2024, and is projected to grow at a CAGR of 8.74%, to USD 29.26 billion by 2030.

Bone marrow transplantation (BMT) involves replacing damaged or diseased bone marrow with healthy marrow stem cells, essential for treating conditions such as leukemia, lymphoma, and other blood disorders. It encompasses autologous, allogeneic, and syngeneic transplant types, each serving different clinical requirements, thereby expanding its applicability across various hematological and immune deficiency conditions. The increasing prevalence of these diseases is compelling the necessity and application of BMT, further driven by advancements in medical technology and supportive government policies. Significant growth influences include rising awareness about BMT, improved success rates, and a growing number of stem cell donors. However, the market faces challenges such as high procedural costs, stringent regulations, and the risk of complications like graft-versus-host disease, which can limit its growth trajectory.

KEY MARKET STATISTICS
Base Year [2023] USD 16.27 billion
Estimated Year [2024] USD 17.62 billion
Forecast Year [2030] USD 29.26 billion
CAGR (%) 8.74%

The end-use scope primarily spans hospitals, clinics, and specialized cancer treatment centers which are increasingly investing in advanced BMT facilities to enhance treatment efficacy and patient outcomes. Recent market insights reveal that ongoing developments in genetic matching technologies and cryopreservation of stem cells present potential opportunities. Businesses in the sector can capitalize on these trends by focusing on personalized medicine and improving logistics for donor-recipient matching systems. Moreover, innovations in reducing post-transplant complications offer valuable research and development avenues for industry stakeholders. To mitigate limitations, there is a pressing need for cost-effective treatment protocols and patient-centric care models.

The market's nature is dynamic, with a robust inclination towards research in regenerative medicine and genomics, providing fertile ground for innovation. Companies focusing on integration of artificial intelligence in treatment planning and leveraging telemedicine for consultation can enhance accessibility and operational efficiency. By prioritizing collaborations with academic and research institutions to foster innovation, stakeholders can secure a competitive edge. Thus, targeting advancements in immunotherapy, enhancing global donor registries, and investing in public awareness campaigns are strategic steps for capturing emerging market opportunities and driving sustainable growth in the BMT market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of blood cancer and improving accessibility to bone marrow transplantation
    • Increased commercialization of cell therapy and tissue engineering products
    • Government initiatives to improve awareness of the therapy
  • Market Restraints
    • High cost of the treatment and lack of reimbursement
  • Market Opportunities
    • Technological advancements in bone marrow transplantation therapy
    • Ongoing research & development activities of BMT
  • Market Challenges
    • Concerns related to GVHD, infections and relapse

Porter's Five Forces: A Strategic Tool for Navigating the Bone Marrow Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Marrow Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Marrow Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Marrow Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Marrow Transplantation Market

A detailed market share analysis in the Bone Marrow Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Marrow Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Marrow Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Marrow Transplantation Market

A strategic analysis of the Bone Marrow Transplantation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Marrow Transplantation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Type Culture Collection, Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Eli Lilly and Company, FUJIFILM Cellular Dynamics, Inc., Gamida Cell, Hemacare Corporation, Lifeline Cell Technology, Lonza Group AG, Magenta Therapeutics, Inc., Merck KgaA, Mesoblast Ltd., Novartis AG, PromoCell GmbH, Qiagen N.V., ReeLabs Pvt. Ltd., Sanofi-Aventis LLC, ScienCell Research Laboratories, Inc., and STEMCELL Technologies Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Marrow Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allogeneic Transplant and Autologous Transplant.
  • Based on Treatment Type, market is studied across Aplastic Anemia, Leukemia, Lymphoma, Myelodysplastic Syndrome, Myeloma, Myeloproliferative Disorders, Sickle cell Anemia, Solid Tumors, and Thalassemia.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Multi-Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
      • 5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
      • 5.1.1.3. Government initiatives to improve awareness of the therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the treatment and lack of reimbursement
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in bone marrow transplantation therapy
      • 5.1.3.2. Ongoing research & development activities of BMT
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to GVHD, infections and relapse
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Marrow Transplantation Market, by Type

  • 6.1. Introduction
  • 6.2. Allogeneic Transplant
  • 6.3. Autologous Transplant

7. Bone Marrow Transplantation Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Aplastic Anemia
  • 7.3. Leukemia
  • 7.4. Lymphoma
  • 7.5. Myelodysplastic Syndrome
  • 7.6. Myeloma
  • 7.7. Myeloproliferative Disorders
  • 7.8. Sickle cell Anemia
  • 7.9. Solid Tumors
  • 7.10. Thalassemia

8. Bone Marrow Transplantation Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Multi-Specialty Clinics

9. Americas Bone Marrow Transplantation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bone Marrow Transplantation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bone Marrow Transplantation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. American Type Culture Collection
  • 3. Bayer AG
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bristol Myers Squibb
  • 7. Eli Lilly and Company
  • 8. FUJIFILM Cellular Dynamics, Inc.
  • 9. Gamida Cell
  • 10. Hemacare Corporation
  • 11. Lifeline Cell Technology
  • 12. Lonza Group AG
  • 13. Magenta Therapeutics, Inc.
  • 14. Merck KgaA
  • 15. Mesoblast Ltd.
  • 16. Novartis AG
  • 17. PromoCell GmbH
  • 18. Qiagen N.V.
  • 19. ReeLabs Pvt. Ltd.
  • 20. Sanofi-Aventis LLC
  • 21. ScienCell Research Laboratories, Inc.
  • 22. STEMCELL Technologies Inc.

LIST OF FIGURES

  • FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE MARROW TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY ALLOGENEIC TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AUTOLOGOUS TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY APLASTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023